Prospective Evaluation of Topical Almond Oil vs Hydroquinone

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of California, Davis

About this trial

The purpose of this study is to analyze facial pigmentation and skin microbiome changes after topical almond oil application, compared to the use of topical hydroquinone.

Eligibility criteria

Qualifiers

Premenopausal women of Fitzpatrick skin types 3 to 6

Disqualifiers

Those with a nut allergy

Smoking is an independent risk factor and serves as a confounder for the development of facial aging [18]. Therefore current smokers, those that have smoked within the past year, and former smokers with greater than a 20 pack year history of smoking will be excluded.

Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehlers-Danlos syndrome) will be excluded as this can be a confounder for facial photoaging.

Hormonal medications or therapies will not be allowed unless they have been stable on their medications for at least 2 months. Examples include oral contraceptives, progesterone-based injections, and estrogen based hormonal replacement therapy.

Trial design

Treatments tested in this trial

  • Almond Oil
  • Hydroquinone Topical

Treatment groups

50 Participants
are divided into 2 treatment groups